THERACRYF PLC
Develops sulforaphane-based medicines for behavioural brain disorders and oncology.
TCF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVN2C70 (+2 more)
- LEI:
- 213800NO3E6TSTQO8K20
- Country:
- United Kingdom
- Address:
- SUITE 24G13 - BLOCK 24, SK10 4TG NETHER ALDERLEY
- Website:
- https://theracryf.com/
Description
TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-03 08:20 |
Half-year Financial Report
|
English | 203.1 KB | ||
| 2025-11-26 08:25 |
Marking Addiction Awareness Week
|
English | 15.6 KB | ||
| 2025-11-24 08:25 |
Notice of Results
|
English | 12.5 KB | ||
| 2025-11-03 08:30 |
Ox-1 Programme Achieves Manufacturing Milestone
|
English | 16.3 KB | ||
| 2025-10-10 08:00 |
World Mental Health Day & Q4 Conference Schedule
|
English | 16.5 KB | ||
| 2025-09-26 16:45 |
Holding(s) in Company
|
English | 23.5 KB | ||
| 2025-09-08 12:38 |
Holding(s) in Company
|
English | 23.9 KB | ||
| 2025-09-04 08:00 |
Ox-1 Patent Grant & Development Programme Update
|
English | 17.3 KB | ||
| 2025-08-04 16:27 |
Holding(s) in Company
|
English | 23.3 KB | ||
| 2025-07-17 08:00 |
Manufacturing Scale Up of Lead Ox-1 Programme
|
English | 14.1 KB | ||
| 2025-07-09 16:07 |
Result of AGM
|
English | 12.3 KB | ||
| 2025-06-16 17:10 |
Notice of AGM
|
English | 13.0 KB | ||
| 2025-06-10 13:32 |
Ox-1 Investor Presentation
|
English | 11.6 KB | ||
| 2025-06-03 08:00 |
Final results for year to 31 March 2025
|
English | 235.9 KB | ||
| 2025-05-23 08:14 |
Notice of Results and Ox-1 presentation
|
English | 12.5 KB |
Automate Your Workflow. Get a real-time feed of all THERACRYF PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for THERACRYF PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for THERACRYF PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
